Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas
Authors:
- 22 June 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 145 (6) , 815-825
Abstract
Objectives: Given frequent inactivating mutations in a chromatin-remodeling gene (ARID1A) in intrahepatic cholangiocarcinoma in recent exome sequencing analysis, this study investigates the clinicopathologic significance of the loss of ARID1A expression in biliary carcinomas. Methods: We examined the inactivating mutations in ARID1A by immunohistochemistry and the relationship with clinicopathologic features in 13 patients with combined hepatocellular-cholangiocarcinoma (cHC-CC), 49 with intrahepatic cholangiocarcinoma (ICC), 17 with intraductal papillary neoplasm of the bile duct (IPNB), 72 with extrahepatic cholangiocarcinoma (EHCC), and 43 with gallbladder carcinoma (GBC). Results: The loss of ARID1A expression was detected in one (7.7%) cHC-CC, nine (18.4%) ICCs, zero IPNBs, 11 (15.3%) EHCCs, and four (9.1%) GBCs. Biliary carcinomas with loss of ARID1A expression showed distinct features; all were macroscopically mass forming or a flat-infiltrating type and histologically tubular adenocarcinoma with abundant fibrous stroma. IPNB, papillary adenocarcinoma, and biliary intraepithelial neoplasia (BilIN) did not harbor loss of ARID1A expression. There was no significant correlation between loss of ARID1A expression and TNM factors or International Union Against Cancer stage. There was no biliary carcinoma harboring both loss of ARID1A expression and KRAS mutations. Conclusions: Inactivating mutations in ARID1A may be involved in a novel pathway of carcinogenesis in biliary carcinomas, which is different from the pathway via IPNB and BilIN associated with KRAS mutations.Keywords
This publication has 32 references indexed in Scilit:
- Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?Hepatology, 2012
- Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial NeoplasiaGastroenterology, 2012
- A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: Is the biliary tract an incomplete pancreas?Pathology International, 2010
- CholangiocarcinomaHepatology, 2008
- A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2006
- Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasisJournal of Hepatology, 2006
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?Journal of Hepatology, 2004
- Characterization of Apomucin Expression in Intrahepatic Cholangiocarcinomas and Their Precursor Lesions: An Immunohistochemical StudyHepatology, 1996
- Intrahepatic peribiliary glands of humans. II. Pathological spectrumJournal of Gastroenterology and Hepatology, 1994
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988